- Home
- DSL vs INMD Comparison
DSL vs INMD Comparison
Compare DSL & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSL
- INMD
- Stock Information
- Founded
- DSL 2013
- INMD 2008
- Country
- DSL United States
- INMD Israel
- Employees
- DSL N/A
- INMD N/A
- Industry
- DSL Trusts Except Educational Religious and Charitable
- INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- DSL Finance
- INMD Health Care
- Exchange
- DSL Nasdaq
- INMD Nasdaq
- Market Cap
- DSL 1.4B
- INMD 1.4B
- IPO Year
- DSL N/A
- INMD 2019
- Fundamental
- Price
- DSL $12.52
- INMD $18.01
- Analyst Decision
- DSL
- INMD Buy
- Analyst Count
- DSL 0
- INMD 6
- Target Price
- DSL N/A
- INMD $22.60
- AVG Volume (30 Days)
- DSL 412.7K
- INMD 1.1M
- Earning Date
- DSL 01-01-0001
- INMD 10-30-2024
- Dividend Yield
- DSL 10.30%
- INMD N/A
- EPS Growth
- DSL N/A
- INMD N/A
- EPS
- DSL N/A
- INMD 1.84
- Revenue
- DSL N/A
- INMD $423,746,000.00
- Revenue This Year
- DSL N/A
- INMD N/A
- Revenue Next Year
- DSL N/A
- INMD $3.13
- P/E Ratio
- DSL N/A
- INMD $9.80
- Revenue Growth
- DSL N/A
- INMD N/A
- 52 Week Low
- DSL $10.22
- INMD $14.87
- 52 Week High
- DSL $12.96
- INMD $26.80
- Technical
- Relative Strength Index (RSI)
- DSL 40.76
- INMD 49.83
- Support Level
- DSL $12.55
- INMD $19.11
- Resistance Level
- DSL $12.77
- INMD $19.85
- Average True Range (ATR)
- DSL 0.14
- INMD 0.62
- MACD
- DSL 0.00
- INMD -0.01
- Stochastic Oscillator
- DSL 34.13
- INMD 37.20
About DSL DoubleLine Income Solutions Fund of Beneficial Interests
DoubleLine Income Solutions Fund is a closed-end fund. The fund's primary investment objective is to seek high income and its secondary objective is to seek capital appreciation. It invests in securities, including money market funds, foreign corporate bonds, us corporate bonds, bank loans, collateralized loan obligations, and municipal bonds. The portfolio of the fund consists of various industries such as Healthcare, Technology, Construction, Automotive, Insurance, Beverage, Pharmaceuticals, Leisure, and others.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.